Analysis of biomarkers and mechanisms of late effects after hematopoietic cell transplantation
Project/Area Number |
18K08345
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Review Section |
Basic Section 54010:Hematology and medical oncology-related
|
Research Institution | National Cancer Center Japan |
Principal Investigator |
INAMOTO YOSHIHIRO 国立研究開発法人国立がん研究センター, 中央病院, 医長 (70730349)
|
Project Period (FY) |
2018-04-01 – 2022-03-31
|
Project Status |
Completed (Fiscal Year 2021)
|
Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2021: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2020: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2019: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2018: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
|
Keywords | 造血細胞移植 / 晩期障害 / バイオマーカー / 移植片対宿主病 / 二次がん / 遺伝子解析 |
Outline of Final Research Achievements |
We identified Dickkopf-related protein 3 (DKK3), a Wnt signaling modulator, as a novel plasma biomarker for chronic graft-versus-host disease (GVHD) including fibrotic phenotype. We demonstrated the utility of plasma MMP9 for diagnosis and response prediction of bronchiolitis obliterans syndrome to FAM therapy. We characterized and compared the incidence, manifestations and treatment outcomes of chronic GVHD and late acute GVHD between Japanese and Caucasian patients. I participated in a member of 2020 NIH Consensus Development Project on Criteria for Clinical Trials in Chronic GVHD and published several meeting reports. By using national transplant registry database and national cancer registration database, we reported outcomes of patients who developed subsequent solid cancer after hematopoietic cell transplantation. By using national transplant registry database, we characterized myeloid neoplasms following allogeneic hematopoietic cell transplantation.
|
Academic Significance and Societal Importance of the Research Achievements |
本研究は海外との共同研究も行いながら、同種造血細胞移植後の大きな課題である慢性GVHDの診断や病態だけでなく治療効果と予後に関連した新規バイオマーカーを報告した。慢性GVHDの治療効果を予測するバイオマーカーの報告は現在限られており、貴重な学術成果が得られたものと考えられる。将来治療への応用が進めば、治療成績の向上につながる可能性があり、社会的意義は大きい。また、移植後の長期生存の妨げとなる二次がんのうち、固形がんと骨髄系腫瘍の大規模なレジストリコホート解析の結果を報告したことの意義は大きく、今後病態解明のためのゲノム解析を進める上での重要な基礎データとなる。
|
Report
(5 results)
Research Products
(34 results)
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[Journal Article] Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases2020
Author(s)
Kahn JM, Brazauskas R, Tecca HR, Bo-Subait S, Buchbinder D, Battiwala M, Flowers MED, Savani BN, Phelan R, Broglie L, Abraham AA, Keating AK, Daly A, Wirk B, George B, Alter BP, Ustun C, Freytes CO, Beitinjaneh AM, Duncan C, Copelan E, Hildebrandt GC, Murthy HS, Lazarus HM, Auletta JJ, Myers KC, Inamoto Y, et al.
-
Journal Title
Blood Advances
Volume: 4
Issue: 9
Pages: 2084-2094
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
-
[Journal Article] Refined National Institutes of Health response algorithm for chronic graft-versus-host disease in joints and fascia2020
Author(s)
Inamoto Y, Lee SJ, Onstad LE, Flowers MED, Hamilton BK, Jagasia MH, Martin PJ, Pavletic SZ, Pidala JA, Pusic I, Vogelsang GB, Wolff D, Carpenter PA.
-
Journal Title
Blood Adv.
Volume: 4
Pages: 40-46
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] Comparison of characteristics and outcomes of late acute and NIH chronic GVHD between Japanese and white patients2019
Author(s)
Inamoto Y, White J, Ito R, Martin PJ, Fatobene G, Ito A, Tanaka T, Kurosawa S, Kim SW, Bar M, Sorror ML, Sandmaier BM, Lee SJ, Fukuda T, Flowers MED.
-
Journal Title
Blood Adv.
Volume: 3
Pages: 2764-2777
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
-
[Journal Article] High probability of follow-up termination among AYA survivors after allogeneic hematopoietic cell transplantation2019
Author(s)
Miyamura K, Yamashita T, Atsuta Y, Ichinohe T, Kato K, Uchida N, Fukuda T, Ohashi K, Ogawa H, Eto T, Inoue M, Takahashi S, Mori T, Kanamori H, Yabe H, Hama A, Okamoto S, Inamoto Y.
-
Journal Title
Blood Adv.
Volume: 3
Pages: 397-405
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Characterization of Late Acute and Chronic Graft-Versus-Host Disease according to the 2014 National Institutes of Health Consensus Criteria in Japanese Patients2019
Author(s)
Ito R, Inamoto Y, Inoue Y, Ito A, Tanaka T, Fuji S, Okinaka K, Kurosawa S, Kim SW, Yamashita T, Fukuda T.
-
Journal Title
Biol Blood Marrow Transplant.
Volume: 25
Pages: 293-300
Related Report
Peer Reviewed
-
[Journal Article] Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b-cell lymphoma.2018
Author(s)
Myers RM, Hill BT, Shaw BE, Kim S, Millard HR, Battiwalla M, Majhail NS, Buchbinder D, Lazarus HM, Savani BN, Flowers MED, D'Souza A, Ehrhardt MJ, Langston A, Yared JA, Hayashi RJ, Daly A, Olsson RF, Inamoto Y et al.
-
Journal Title
Cancer.
Volume: 124
Pages: 816-825
Related Report
Peer Reviewed / Int'l Joint Research
-
[Journal Article] ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors.2018
Author(s)
Hashmi SK, Lee SJ, Savani BN, Burns L, Wingard JR, Perales MA, Palmer J, Chow E, Meyer E, Marks D, Mohty M, Inamoto Y et al.
-
Journal Title
Biol Blood Marrow Transplant.
Volume: 24
Pages: 1119-1124
Related Report
Peer Reviewed / Int'l Joint Research
-
[Journal Article] Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma.2018
Author(s)
Radivoyevitch T, Dean RM, Shaw BE, Brazauskas R, Tecca HR, Molenaar RJ, Battiwalla M, Savani BN, Flowers MED, Cooke KR, Hamilton BK, Kalaycio M, Maciejewski JP, Ahmed I, Akpek G, Bajel A, Buchbinder D, Cahn JY, D'Souza A, Daly A, DeFilipp Z, Ganguly S, Hamadani M, Hayashi RJ, Hematti P, Inamoto Y et al.
-
Journal Title
Leuk Res.
Volume: 74
Pages: 130-136
Related Report
Peer Reviewed / Int'l Joint Research
-
[Journal Article] Outcomes of patients who developed subsequent solid cancer after hematopoietic cell transplantation.2018
Author(s)
Inamoto Y, Matsuda T, Tabuchi K, Kurosawa S, Nakasone H, Nishimori H, Yamasaki S, Doki N, Iwato K, Mori T, Takahashi S, Yabe H, Kohno A, Nakamae H, Sakura T, Hashimoto H, Sugita J, Ago H, Fukuda T, Ichinohe T, Atsuta Y, Yamashita T
-
Journal Title
Blood Adv.
Volume: 2
Pages: 1901-1913
NAID
Related Report
Peer Reviewed / Open Access
-
[Presentation] Incidence, Risk Factors and Outcomes of Therapy-Related Myeloid Malignancies after Hematopoietic Cell Transplantation: Analysis of the Japan Society for Hematopoietic Cell Transplantation Late Complications and QOL Working Group2020
Author(s)
Kuno M, Yamasaki S, Fukuda T, Mori T, Uchida N, Katayama Y, Onizuka M, Ichinohe T, Atsuta Y, Inamoto Y
Organizer
Transplant and Cellular Therapy meeting
Related Report
Int'l Joint Research
-
[Presentation] Comparison of characteristics and outcomes of late acute and chronic graft-versus-host disease between Japanese and White patients2019
Author(s)
Inamoto Y, White J, Ito R, Martin PJ, Fatobene G, Ito A, Tanaka T, Kurosawa S, Kim SW, Bar M, Lee SJ, Fukuda T, Flowers MED.
Organizer
日本血液学会
Related Report